SEARCH

SEARCH BY CITATION

References

  • 1
    Pober, J.S. & Cotran, R.S. (1990) The role of endothelial cells in inflammation. Transplantation 50, 537 544.
  • 2
    Springer, T.A. (1990) Adhesion receptors of the immune system. Nature 346, 425 434.
  • 3
    Languino, L.R., Plescia, J., Duperray, A., Brian, A.A., Plow, E.F., Geltosky, J., Altieri, D.C. (1993) Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1dependent pathway. Cell 73, 1423 1434.
  • 4
    Altieri, D.C., Plescia, J., Plow, E.F. (1993) The structural motif glycine 190–valine 202 of the fibrinogen gamma chain interacts with CD11b/CD18 integrin αmβ2, (Mac-1) and promotes leukocyte adhesion. J. Biol. Chem. 268, 1847 1853.
  • 5
    Bombeli, T., Schwartz, B.R., Harlan, J.M. (1998) Adhesion of activated platelets to endothelial cells: evidence for a GPIIb/IIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), αVβ3 integrin, and GPIbα. J. Exp. Med. 187, 329 339.
  • 6
    Hicks, R.C.J., Golledge, J., Mir-Hasseine, R., Powell, J.T. (1996) Vasoactive effects of fibrinogen on saphenous vein. Nature 379, 818 820.
  • 7
    Gardiner, E.E. & D'Souza, S.E. (1997) A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1. J. Biol. Chem. 272, 15474 15480.
  • 8
    Altieri, D.C., Duperray, A., Plescia, J., Thornton, G.B., Languino, L.R. (1995) Structural recognition of a novel fibrinogen gamma chain sequence (117–133) by intercellular adhesion molecule-1 mediates leukocyte–endothelium interaction. J. Biol. Chem. 270, 696 699.
  • 9
    D'Souza, S.E., Byers-Ward, V.J., Gardiner, E.E., Wang, H., Sung, S.-S. (1996) Identification of an active sequence within the first immunoglobulin domain of intercellular cell adhesion molecule-1 (ICAM-1) that interacts with fibrinogen. J. Biol. Chem. 271, 24270 24277.
  • 10
    Gardiner, E.E. & D'Souza, S.E. (1999) Sequences within fibrinogen and intercellular adhesion molecule-1 (ICAM-1) modulate signals required for mitogenesis. J. Biol. Chem. 274, 11930 11936.
  • 11
    Durieu-Trautmann, O., Chaverot, N., Cazaubon, S., Strosberg, A.D., Couraud, P.-O. (1994) Intercellular adhesion molecule-1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J. Biol. Chem. 269, 12536 12540.
  • 12
    Etienne, S., Adamson, P., Greenwood, J., Strosberg, A.D., Cazaubon, S., Couraud, P.-O. (1998) ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J. Immunol. 161, 5755 5761.
  • 13
    Adamson, P., Sandrine, E., Couraud, P.-O., Virginia, C., Greenwood, J. (1999) Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a Rho-dependent pathway. J. Immunol. 162, 2964 2973.
  • 14
    Traverse, S., Gomez, N., Paterson, H., Marshall, C., Cohen, P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288, 351 355.
  • 15
    Ishida, T., Kovach, N.L., Berk, B.C. (1996) MAP kinase activation by flow in endothelial cells. Role of β1 integrins and tyrosine kinases. Circ. Res. 79, 310 316.
  • 16
    Cowley, S., Paterson, H., Kemp, P., Marshall, C.J. (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841 852.
  • 17
    Mansour, S.J., Matten, W.T., Hermann, A.S., Candia, J.M., Rong, S., Fukasawa, K., Vande Woude, G.F., Ahn, N.G. (1994) Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966 970.
  • 18
    Adams, J.M. & Cory, S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322 1326.
  • 19
    Karsan, A., Yee, E., Kaushansky, K., Harlan, J.M. (1996) Cloning of a human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Biochem. Biophys. Res. Commun. 210, 1076 1082.
  • 20
    Grumont, R.J., Rourke, I.J., Gerondakis, S. (1999) Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13, 400 411.
  • 21
    Karsan, A., Yee, E., Harlan, J.M. (1996) Endothelial cell death induced by tumor necrosis factor-α is inhibited by the Bcl-2 family member, A1. J. Biol. Chem. 271, 27201 27204.
  • 22
    Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J., Saltiel, A.R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl Acad. Sci. USA 92, 7686 7689.
  • 23
    Shankar, R., de la Motte, C., Poptic, E.J., DiCorleto, P.E. (1994) Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J. Biol. Chem. 269, 13936 13941.
  • 24
    David, M., Petricoin, E., Benjamin, C., Pine, R., Weber, M.J., Larner, A.C. (1995) Requirement for MAPK kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins. Science 269, 1721 1723.
  • 25
    Chin, B.Y., Petrache, I., Choi, A.M.K., Choi, M.E. (1999) Transforming growth factor β1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages. J. Biol. Chem. 274, 11362 11368.
  • 26
    Budzynski, A.Z., Marder, V.J., Shainoff, J.R. (1974) Structure of plasmic degradation products of human plasmin and fibrinogen: fibrinopeptide and polypeptide chain analysis. J. Biol. Chem. 249, 2294 2302.
  • 27
    Hanke, J.H., Gardner, J.P., Dow, R.L., Changelian, P.S., Brissette, W.H., Weringer, E.J., Pollok, B.A., Connelly, P.A. (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J. Biol. Chem. 271, 695 791.
  • 28
    Salazar, E.P. & Rozengurt, E. (1999) Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells. J. Biol. Chem. 274, 28371 28378.
  • 29
    Cheresh, D.A., Berliner, S.A., Vicente, V., Ruggeri, Z.M. (1989) Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 58, 945 953.
  • 30
    Bach, T.L., Barsigian, C., Yaen, C.H., Martinez, J. (1998) Endothelial cell VE-cadherin functions as a receptor for the beta 15–42 sequence of fibrin. J. Biol. Chem. 273, 30719 30728.
  • 31
    Evan, G. & Littlewood, T. (1998) A matter of life and cell death. Science 281, 1317 1322.
  • 32
    Marshall, C.J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179 185.
  • 33
    Bornfeldt, K.E., Campbell, J.S., Koyama, H., Argast, G.M., Leslie, C.C., Raines, E.W., Krebs, E.G., Ross, R. (1997) The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. J. Clin. Invest. 100, 875 885.
  • 34
    Xu, Q., Liu, Y., Gorospe, M., Udelsman, R., Holbrook, N.J. (1996) Acute hypertension activates mitogen-activated protein kinases in arterial wall. J. Clin. Invest. 97, 508 514.
  • 35
    Leevers, S.J., Paterson, H.F., Marshall, C.J. (1994) Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369, 411 414.
  • 36
    Weber, J.D., Raben, D.M., Phillips, P.J., Baldassare, J.J. (1997) Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem. J. 326, 61 68.
  • 37
    Nadal, F., Levy-Toledano, S., Grelac, F., Caen, J.P., Rosa, J.-P., Bryckaert, M. (1997) Negative regulation of mitogen-activated protein kinase activation by integrin αIIbβ3 in platelets. J. Biol. Chem. 272, 22381 22384.
  • 38
    Klemke, R.L., Cai, S., Giannini, A.L., de Gallagher, P.J., Lanerolle, P., Cheresh, D.A. (1997) Regulation of cell motility by mitogen-activated protein kinase. J. Cell. Biol. 137, 481 492.
  • 39
    Madhani, H.D., Styles, C.A., Fink, G.R. (1997) MAP kinases with distinct inhibitory functions impart signaling specificity during yeast differentiation. Cell 91, 673 684.
  • 40
    Saklatvala, J., Davis, W., Guesdon, F. (1996) Interleukin 1 (IL1) and tumour necrosis factor (TNF) signal transduction. Phil. Trans. R. Soc. (Lond.) 351, 151 157.
  • 41
    Brondello, J.M., Brunet, A., Pouyssegur, J., McKenzie, F.R. (1997) The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 272, 1368 1376.
  • 42
    Lai, K., Wang, H., Lee, W.-S., Jain, M.K., Lee, M.-E., Haber, E. (1996) Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J. Clin. Invest. 98, 1560 1567.
  • 43
    Cambien, B., Millet, M.A., Schmid-Antomarchi, H., Brossette, N., Rossi, B., Schmid-Alliana, A. (1999) Src-regulated extracellular signal-related kinase and Syk-regulated c-Jun N-terminal kinase pathways act in conjunction to induce IL-1 synthesis in response to microtubule disruption in HL60 cells. J. Immunol. 163, 5079 5085.
  • 44
    Stone, A.A. & Chambers, T.C. (2000) Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Exp. Cell Res. 254, 110 119.
  • 45
    Walker, F., Kato, A., Gonez, L.J., Hibbs, M.L., Pouliot, N., Levitzki, A., Burgess, A.W. (1998) Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation. Mol. Cell. Biol. 12, 7192 7204.
  • 46
    Horiuchi, M., Hayashida, W., Kambe, T., Yamada, T., Dzau, V.J. (1997) Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phophatase-1 and induces apoptosis. J. Biol. Chem. 272, 19022 19026.
  • 47
    Bini, A., Fenoglio, J.J., Mesa-Tejada, R., Kudryk, B., Kaplan, K.L. (1989) Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9, 109 121.
  • 48
    Valenzuela, R., Shainoff, J.R., DiBello, P.M., Urbanic, D.A., Anderson, J.M., Matsueda, G.R., Kudryk, B.J. (1992) Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas. Am. J. Pathol. 141, 861 880.
  • 49
    Zong, W.-X., Edelstein, L.C., Chen, C., Bash, J., Gelinas, C. (1999) The prosurvival Bcl-1 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13, 382 387.
  • 50
    Gille, H., Sharrocks, A.D., Shaw, P.E. (1992) Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358, 414 417.
  • 51
    Davis, R.J. (1993) The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268, 14553 14556.
  • 52
    Massberg, S., Enders, G., de Melo Matos, F.C., Domschke Tomic, L.I., Leiderer, R., Eisenmenger, S., Messmer, K., Krombach, F. (1999) Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 94, 3829 3838.